Factors influencing the development of lipodystrophy in human immunodeficiency virus-infected patients

被引：5

作者：

Collazos, J ^{[1
]}

Rodriguez-Guardado, A

Maradona, JA

Mayo, J

Asensi, V

Ibarra, S

Carton, JA

Casado, L

机构：

[1] Hosp Galdacano, Infect Dis Unit, Vizcaya 48960, Spain

[2] Univ Oviedo, Hosp Cent Asturias, Infect Dis Unit, E-33080 Oviedo, Spain

来源：

SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES | 2003年 / 35卷 / 05期

关键词：

D O I：

10.1080/00365540310008393

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

238 human immunodeficiency virus-infected patients on highly active antiretroviral therapy (HAART) were studied, 67 of whom (28.2%) developed lipodystrophy. The presence of hyperlipidaemia (p = 0.002) and of hepatitis C virus coinfection (p = 0.014) were associated with lipodystrophy, but only the duration of HAART was significantly predictive of lipodystrophy (p < 0.0001) in the multivariate analysis.

引用

页码：339 / 340

页数：2

共 12 条

[1] Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study [J].

Carr, A ;

Samaras, K ;

Thorisdottir, A ;

Kaufmann, GR ;

Chisholm, DJ ;

Cooper, DA .

LANCET, 1999, 353 (9170) :2093-2099

[2] A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors [J].

Carr, A ;

Samaras, K ;

Burton, S ;

Law, M ;

Freund, J ;

Chisholm, DJ ;

Cooper, DA .

AIDS, 1998, 12 (07) :F51-F58

[3] Serum lipid and lipoprotein patterns in patients with liver cirrhosis and chronic active hepatitis [J].

Cicognani, C ;

Malavolti, M ;

MorselliLabate, AM ;

Zamboni, L ;

Sama, C ;

Barbara, L .

ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (07) :792-796

[4] Hyperlipidemia in HIV-infected patients: the protective effect of hepatitis C virus co-infection [J].

Collazos, J ;

Mayo, J ;

Ibarra, S ;

Cazallas, J .

AIDS, 2003, 17 (06) :927-929

[5]

Duong M, 2001, J ACQ IMMUN DEF SYND, V27, P245, DOI 10.1097/00126334-200107010-00005

[6] Blood lipids of patients with chronic hepatitis: Differences related to viral etiology [J].

Fabris, C ;

Federico, E ;

Soardo, G ;

Falleti, E ;

Pirisi, M .

CLINICA CHIMICA ACTA, 1997, 261 (02) :159-165

[7] Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy [J].

Gervasoni, C ;

Ridolfo, AL ;

Trifirò, G ;

Santambrogio, S ;

Norbiato, G ;

Musicco, M ;

Clerici, M ;

Galli, M ;

Moroni, M .

AIDS, 1999, 13 (04) :465-471

[8] Hepatitis C virus in patients with HIV infection and lipodystrophy [J].

Rodriguez-Guardado, A ;

Maradona, JA ;

Asensi, V ;

Cartón, JA ;

Casado, L .

JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2003, 32 (03) :348-349

[9] A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy [J].

Saint-Marc, T ;

Partisani, M ;

Poizot-Martin, I ;

Bruno, F ;

Rouviere, O ;

Lang, JM ;

Gastaut, JA ;

Touraine, JL .

AIDS, 1999, 13 (13) :1659-1667

[10] Factors related to lipodystrophy and metabolic alterations in patients with human immunodeficiency virus infection receiving highly active antiretroviral therapy [J].

Savès, M ;

Raffi, F ;

Capeau, J ;

Rozenbaum, W ;

Ragnaud, JM ;

Perronne, C ;

Basdevant, A ;

Leport, C ;

Chêne, G .

CLINICAL INFECTIOUS DISEASES, 2002, 34 (10) :1396-1405

← 1 2 →